kirk perry kenvue ceo

Order byBest matchMost fresh

Kenvue, Tylenol

Tylenol maker Kenvue ousts CEO amid board's strategic review

Kenvue's board has already launched a strategic review, which will include examining options to simplify operations and potentially sell off certain brands, the company said on Monday.

· 22h · on MSN

Kirk Perry Appointed Interim CEO of Kenvue Amid Strategic Review

· 1d · on MSN

Tylenol-maker Kenvue fires CEO Thibaut Mongon

· 1d

Kenvue CEO Mongon Stepping Down as Company Continues With Strategic Review

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company.

· 1d

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood

· 1d

Kenvue Seeks Its Own Band-Aid With CEO Departure and Strategic Review. The Stock Rises.

· 8h

Kenvue: New CEO, Watch The Dividend (Rating Downgrade)

High debt load and rising rates strain Kenvue’s free cash flow and dividend sustainability.

SchaeffersResearch.com · 1d

Call Traders Circle Tylenol Parent Amid C-Suite Swap

· 1d

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29

Fierce Pharma4h

Consumer health giant Kenvue kicks off CEO transition as sales slip

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is taking big steps in its strategic review that has now resulted in a leadersh | Along with the CEO transition announcement,

Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut